Aurora Cannabis Inc. (TSX:ACB)

Market Cap	457.73M
Revenue (ttm)	320.81M
Net Income (ttm)	5.02M
Shares Out	54.88M
EPS (ttm)	0.09
PE Ratio	25.39
Forward PE	9.27
Dividend	n/a
Ex-Dividend Date	n/a

Volume	841,182
Average Volume	931,472
Open	8.50
Previous Close	8.30
Day's Range	8.23 - 8.89
52-Week Range	3.84 - 12.85
Beta	2.58
RSI	60.03
Earnings Date	Feb 7, 2025

About Aurora Cannabis

Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally. It operates through two segments, Canadian Cannabis and Plant Propagation. The company offers medical and consumer cannabis products; supplies propagated vegetables and ornamental plants; and distributes and sells hemp-derived cannabidiol (CBD) products. The company also cultivates and sells dried cannabis, cannabis oils, capsules, edible cannabis, cannabis extracts, ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2013
• Employees: 1,073
• Stock Exchange: Toronto Stock Exchange
• Ticker Symbol: ACB

Financial Performance

In 2023, Aurora Cannabis's revenue was 270.28 million, an increase of 20.77% compared to the previous year's 223.80 million. Losses were -65.58 million, -91.97% less than in 2022.